Clinical Trial Update: A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effects of PT001 and PT005 MDI on image-based parameters in subjects with moderate to severe COPD has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PT001
• PT005 MDI

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: COPD, Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-07-24